American Century Companies Inc. Raises Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

American Century Companies Inc. lifted its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 628.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,739,323 shares of the company’s stock after purchasing an additional 1,500,485 shares during the period. American Century Companies Inc. owned 2.03% of Pediatrix Medical Group worth $22,820,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the company. State Street Corp raised its position in Pediatrix Medical Group by 1.4% during the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares in the last quarter. Pacer Advisors Inc. bought a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at about $35,492,000. Boston Partners raised its holdings in shares of Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after acquiring an additional 393,600 shares in the last quarter. Geode Capital Management LLC lifted its stake in Pediatrix Medical Group by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock worth $22,452,000 after acquiring an additional 45,155 shares during the period. Finally, Weiss Asset Management LP grew its holdings in Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after acquiring an additional 306,143 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $14.15 on Monday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a market cap of $1.21 billion, a PE ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The stock has a fifty day moving average price of $14.40 and a 200-day moving average price of $13.69.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

MD has been the subject of several research reports. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price for the company. Truist Financial lifted their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Finally, UBS Group upped their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.